The report offers several significant contributions to the literature, i.e., the association of anti-recoverin antibodies with a broader clinical picture than previously recognized, such as myelitis, the association of RSV vaccination with LETM, and lastly, the potential role of anti-recoverin antibodies in vaccine adverse reactions. This evidence concerns the gene RCVRN and myelitis.